We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$14.9B
AUM Growth
+$373M
Cap. Flow
+$123M
Cap. Flow %
0.82%
Top 10 Hldgs %
56.71%
Holding
1,166
New
198
Increased
342
Reduced
449
Closed
173

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$32M
2
AVGO icon
Broadcom
AVGO
+$31.6M
3
VZ icon
Verizon
VZ
+$27.3M
4
CCJ icon
Cameco
CCJ
+$26.1M
5
MPLX icon
MPLX
MPLX
+$23.1M

Sector Composition

Rank Sector Weight
1 Energy 66.42%
2 Technology 4.66%
3 Financials 3.55%
4 Consumer Discretionary 3.47%
5 Healthcare 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDY icon
601
Dr. Reddy's Laboratories
RDY
$9.8B
$529K ﹤0.01%
33,310
-1,500
-4% -$24.1K
CIB icon
602
Grupo Cibest SA
CIB
$20.9B
$529K ﹤0.01%
16,844
+1,500
+10% +$49.2K
EXPE icon
603
Expedia Group
EXPE
$33.4B
$528K ﹤0.01%
+3,564
New +$472K
VBTX
604
DELISTED
Veritex Holdings
VBTX
$523K ﹤0.01%
19,866
-1,617
-8% -$38.3K
ETD icon
605
Ethan Allen Interiors
ETD
$592M
$521K ﹤0.01%
16,349
-1,005
-6% -$30.3K
TRML
606
DELISTED
Tourmaline Bio
TRML
$508K ﹤0.01%
19,773
-216
-1% -$3.6K
CPT icon
607
Camden Property Trust
CPT
$11.2B
$508K ﹤0.01%
4,115
-193
-4% -$22.8K
ARCT icon
608
Arcturus Therapeutics
ARCT
$164M
$507K ﹤0.01%
21,838
-8,277
-27% -$177K
INDA icon
609
iShares MSCI India ETF
INDA
$6.77B
$499K ﹤0.01%
8,534
+2,405
+39% +$137K
FLGT icon
610
Fulgent Genetics
FLGT
$556M
$499K ﹤0.01%
22,942
-420
-2% -$9.39K
VLY icon
611
Valley National Bancorp
VLY
$7.94B
$498K ﹤0.01%
54,952
-4,623
-8% -$37.6K
JD icon
612
JD.com
JD
$41.8B
$496K ﹤0.01%
12,392
-1,788
-13% -$49.1K
INVH icon
613
Invitation Homes
INVH
$17.6B
$494K ﹤0.01%
13,997
-1,164
-8% -$41.6K
LEU icon
614
Centrus Energy
LEU
$3.46B
$491K ﹤0.01%
+8,950
New +$374K
ALLO icon
615
Allogene Therapeutics
ALLO
$604M
$491K ﹤0.01%
175,285
+12,427
+8% +$33.1K
IRWD icon
616
Ironwood Pharmaceuticals
IRWD
$644M
$484K ﹤0.01%
117,535
-6,440
-5% -$34.6K
GEF.B icon
617
Greif Class B
GEF.B
$3.8B
$471K ﹤0.01%
6,745
-515
-7% -$34K
PPL
618
PPL Corp
PPL
$27.1B
$471K ﹤0.01%
14,230
-5,660
-28% -$173K
CEG icon
619
Constellation Energy
CEG
$96.4B
$468K ﹤0.01%
+1,800
New +$358K
POWL icon
620
Powell Industries
POWL
$7.99B
$466K ﹤0.01%
6,291
-537
-8% -$29.2K
MLYS icon
621
Mineralys Therapeutics
MLYS
$2.4B
$463K ﹤0.01%
38,264
-471
-1% -$5.7K
UPBD icon
622
Upbound Group
UPBD
$1.2B
$453K ﹤0.01%
14,173
-1,221
-8% -$39.2K
YMAB
623
DELISTED
Y-mAbs Therapeutics
YMAB
$450K ﹤0.01%
34,231
+7
+0% +$89
CELC icon
624
Celcuity
CELC
$4.01B
$449K ﹤0.01%
30,093
+2,714
+10% +$44.7K
ACMR icon
625
ACM Research
ACMR
$5.53B
$443K ﹤0.01%
21,847
+9,727
+80% +$186K

Similar funds

ALPS Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, ALPS Advisors held 1,166 positions worth $14.9B, up 2.6% from $14.6B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

ALPS Advisors's Q3 2024 filing shows 198 new, 342 increased, 449 reduced and 173 closed positions. Its largest new stake was LyondellBasell Industries: 258,651 shares worth $24.8M. The largest sale was JPMorgan Chase, an estimated $32M.

By sector, the portfolio is most concentrated in Energy at 66% of assets, down from 69% a quarter earlier, followed by Technology and Financials.

  • ALPS Advisors's largest Q3 2024 buy was LyondellBasell Industries: 258,651 shares worth $24.8M.
  • ALPS Advisors added most to ENLINK MIDSTREAM, LLC in Q3 2024, an estimated $48.3M increase.
  • ALPS Advisors's biggest Q3 2024 reduction was JPMorgan Chase, cutting an estimated $32M.
  • ALPS Advisors fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $14.5M.
  • ALPS Advisors's ten largest holdings make up 57% of its $14.9B portfolio in Q3 2024.
  • ALPS Advisors opened 198 new positions and closed 173 in Q3 2024.
  • ALPS Advisors's portfolio value rose 2.6% quarter-over-quarter to $14.9B.

Based on ALPS Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.